Research archive
Research published in 2013
64 publications from 2013, newest first.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
- StudyInt J Cancer2013 Nov 15Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells.Vives M, et al.
- Meta-analysisEur J Cancer2013 NovLow-dose metronomic chemotherapy: a systematic literature analysis.Lien K, et al.
- Clinical trialAnticancer Res2013 OctRadiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study.Morganti AG, et al.
- Clinical trialBr J Cancer2013 Oct 1A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.Kelley RK, et al.
- StudyCancer Lett2013 Oct 1Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models.Luo KW, et al.
- Case reportAnticancer Drugs2013 OctEvidence of extended (>7 years) activity of bevacizumab and metronomic cyclophosphamide in a patient with platinum-resistant low-grade serous ovarian carcinoma.Rose PG and Roma A
- Case reportHepat Mon2013Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases.Marinelli S, et al.
- StudyZhongguo Fei Ai Za Zhi2013 Sep[Metronomic chemotherapy combined with dendritic cell vaccine inhibits VEGF secretion].Zhou Y, et al.
- StudyFuture Oncol2013 SepFunctional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer.Cardillo I, et al.
- StudyAnn Oncol2013 SepTherapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas.Mainetti LE, et al.
- StudyBr J Cancer2013 Aug 20VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.Orlandi P, et al.
- ReviewBreast2013 AugPreclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.Kerbel RS, et al.
- ReviewBreast2013 AugPersonalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.Goldhirsch A
- Clinical trialAnticancer Res2013 AugSorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.Zustovich F, et al.
- Clinical trialIndian J Cancer2013 Jul-SepPreliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.Traore F, et al.
- StudyJ Gynecol Oncol2013 JulThe combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer.Barber EL, et al.
- StudyJ Gynecol Oncol2013 JulBevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer.Pujade-Lauraine E
- ReviewCancer Chemother Pharmacol2013 JulMetronomic chemotherapy for cancer treatment: a decade of clinical studies.Romiti A, et al.
- StudyJ Transl Med2013 Jun 18A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.Kandalaft LE, et al.
- StudyBreast Cancer (Dove Med Press)2013Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer.Kader YA, et al.
- StudyInt J Cancer2013 Jun 15Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles.Todorova M, et al.
- Clinical trialVeterinaryJ Am Vet Med Assoc2013 Jun 1Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.Schrempp DR, et al.
- Case reportVeterinaryJ Small Anim Pract2013 JunA novel approach to treatment of lymphangiosarcoma in a boxer dog.Marcinowska A, et al.
- StudyMol Ther2013 JunOncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.Liikanen I, et al.
- CommentaryClin Oncol (R Coll Radiol)2013 JunOral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers.Patil V, et al.
- StudyClin Transl Oncol2013 JunSafety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.Manso L, et al.
- Randomized trialBMC Cancer2013 May 29Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.Briasoulis E, et al.
- Case reportActa Neuropathol Commun2013 May 20Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.Mercurio S, et al.
- CommentaryCNS Oncol2013 MayIs low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors.Wolf DS and Cohen KJ
- StudyCancer Lett2013 Apr 28Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis.Jia L and Waxman DJ
- Case reportVeterinaryJ S Afr Vet Assoc2013 Apr 12Thyroid carcino-sarcoma in a dog.Giuliano A, et al.
- Case reportIndian J Cancer2013 Apr-JunIs there a role for metronomic induction (and maintenance) therapy in elderly patients with acute myeloid leukemia? A literature review.Tandon N, et al.
- Case reportIndian J Cancer2013 Apr-JunCan combination metronomic therapy overcome chemoresistance in cholangiocarcinoma? A literature review.Banavali SD, et al.
- StudyIndian J Cancer2013 Apr-JunOral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis.Pai PS, et al.
- StudyIndian J Cancer2013 Apr-JunEfficacy and safety of metronomic administration of paclitaxel for advanced recurrent non-small-cell lung cancer.Noronha V, et al.
- StudyIndian J Cancer2013 Apr-JunAssociation between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer.Perroud HA, et al.
- StudyOncol Lett2013 AprNail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy.Kibata K, et al.
- Phase 3 trialBreast2013 AprAdjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.Crivellari D, et al.
- StudyCancer Chemother Pharmacol2013 AprA mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.Faivre C, et al.
- StudyMol Cancer Ther2013 AprEfficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.Pratt SE, et al.
- Clinical trialJ Neurosurg2013 AprProspective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.Salmaggi A, et al.
- StudyAngiogenesis2013 AprConcentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells.Pasquier E, et al.
- StudyMol Clin Oncol2013 MarMetronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more.Kontani K, et al.
- StudyGenes Dev2013 Mar 1Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.Soucek L, et al.
- Clinical trialFuture Oncol2013 MarSafety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients.Perroud HA, et al.
- Clinical trialPediatr Blood Cancer2013 MarA pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.Felgenhauer JL, et al.
- Clinical trialJ Endocrinol Invest2013 MarMetronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.Ferrero A, et al.
- Clinical trialJ Chemother2013 FebA phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.Kontopodis E, et al.
- StudyTransl Oncol2013 FebA Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy.Kubisch R, et al.
- Clinical trialNeuro Oncol2013 FebPhase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.Omuro A, et al.
- StudyCancer Immunol Immunother2013 FebMetronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.Tongu M, et al.
- ReviewDrug Discov Today2013 FebLow-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer.Loven D, et al.
- CommentaryGut2013 FebMetronomic topotecan for colorectal cancer: a promising new option.Wang D, et al.
- Meta-analysisEur J Neurol2013 FebThe efficacy of temozolomide for recurrent glioblastoma multiforme.Chen C, et al.
- StudyGut2013 FebMetronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models.Hackl C, et al.
- Case reportHead Neck2013 FebMetastatic adenoid cystic carcinoma of the salivary gland responding to cetuximab plus weekly paclitaxel after no response to weekly paclitaxel alone.Caballero M, et al.
- StudyInt J Pharm2013 Jan 30Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical application.Nagao A, et al.
- Clinical trialOncologist2013Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.Brandi G, et al.
- StudyJ BUON2013 Jan-MarThe role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.Ekinci D, et al.
- StudyOncoimmunology2013 Jan 1Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer.Kandalaft LE, et al.
- StudyClin Med Insights Oncol2013Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer.Ogata Y, et al.
- ReviewFront Biosci (Landmark Ed)2013 Jan 1Recent therapeutic advances and insights of recurrent glioblastoma multiforme.Chen J and Xu T
- StudyBiomaterials2013 JanAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.Luo LM, et al.
- StudyInt J Cancer2013 Jan 1Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.Kim YJ, et al.